Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Johannes Oldenburg, Prof, Dimitrios Tsakiris, Prof, Cedric R. Hermans, MD PhD MRCP, RI Liesner, MD FRCP, FRCPath, MA, MBBChir, Kate Khair, Maria Gabriella Mazzucconi, Prof, Katharina N Steinitz-Trost, PhD, Gerald Spotts, PhD, Armin J Reininger, Prof, Alessandro Gringeri, MD MSc

Blood (2016) 128 (22): 3786.

https://doi.org/10.1182/blood.V128.22.3786.3786

Published: 2016

Journal Articles

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Roberto Crea, DVM, MSc, Aaron Novack, Armin J Reininger, Justine Kennedy, Sandra Raff, Alessandro Gringeri, MD MSc, Naghmana Bajwa

Blood (2016) 128 (22): 5031.

https://doi.org/10.1182/blood.V128.22.5031.5031

Published: 2016

Journal Articles

Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (Feiba R ) in Patients with Inhibitors. First Demographic Data

Ana Rosa Cid, MD, Carmen Escuriola, MD, Cedric R. Hermans, MD PhD MRCP, Pal André Holme, PhD MD, Claude Negrier, MD, Savita Rangarajan, Angiola Rocino, Jerzy Windyga, MD, Alessandro Gringeri, MD MSc, Roberto Crea, DVM, MSc

Blood (2016) 128 (22): 5038.

https://doi.org/10.1182/blood.V128.22.5038.5038

Published: 2016

Journal Articles

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Alessandro Gringeri, MD, MSc, Kathelijn Fischer, MD, PhD, MSc, Anastasia Karafoulidou, MD, Robert Klamroth, MD, Maria Fernanda Lopez, MD, Maria Elisa Mancuso, MD

Blood (2009) 114 (22): 1294.

https://doi.org/10.1182/blood.V114.22.1294.1294

Published: 2009

Journal Articles

Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.

Alfonso Iorio, MD, Susan Halimeh, MD, Christoph Bidlingmaier, MD, Leonardo R. Brandao, MD, Carmen Escuriola-Ettingshausen, MD, Neil A Goldenberg, MD, PhD, Alessandro Gringeri, MD, MSc, Susanne Holzhauer, MD, Gili Kenet, MD, PhD, Ralf Knoefler, MD, Wolfhart Kreuz, MD, Karin Kurnik, MD, Daniela Manner, MD, Emanuela Marchesini, MD, Maura Marcucci, MD, Elena Santagostino, MD, PhD, Guy Young, MD, Pier Mannuccio Mannucci, MD, Ulrike Nowak-Gottl, MD

Blood (2009) 114 (22): 3154.

https://doi.org/10.1182/blood.V114.22.3154.3154

Published: 2009

Journal Articles

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Alessandro Gringeri, MD, MSc, Piermannuccio Mannucci, MD, Mara Monzini, PharmD, Luciana Scalone, PharmD, Lorenzo Mantovani, MSc, DSc

Blood (2004) 104 (11): 2203.

https://doi.org/10.1182/blood.V104.11.2203.2203

Published: 2004

NARROW

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (Feiba R ) in Patients with Inhibitors. First Demographic Data

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Email alerts

ASH Publications

American Society of Hematology

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Feiba Global Outcome Study (FEIBA-GO): Long-Term Real World Data on Apcc (Feiba R ) in Patients with Inhibitors. First Demographic Data

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only